Abstract:Aims/Introduction: Diabetic kidney disease (DKD) is defined as diabetes with impaired renal function, elevated urinary albumin excretion, or both. DKD is one of the most common microvascular complications of diabetes and plays an important role in the cause of end-stage renal disease (ESRD). About 5% of people with type 2 diabetes (T2DM) already have kidney damage at the time they are diagnosed, but other triggers of renal insufficiency, such as obesity, hyperlipidemia, glomerular atherosclerosis are often present, making it difficult to define "diabetic kidney disease" or "diabetic nephropathy" precisely in epidemiology or clinical practice. Therefore, the aim of this study is to identify diabetic patients with CKD at an early stage, and evaluate the value of tubular injury markers including α1-microglobulin (α1-MG), β2-microglobulin (β2-MG), N-acetyl-beta-D-glucosaminidase (NAG) and Urinary retinol binding protein (URBP) in the development of diabetes to DKD. Materials and methods: We recruited a total of 182 hospitalized patients with T2DM in the First Affiliated Hospital of Zhengzhou University from February 2018 to April 2023. We collected basic clinical characteristics and laboratory biochemical parameters of the patients. Based on their levels of urinary albumin creatinine ratio (UACR) and glomerular filtration rate (GFR), patients were divided into DM group (UACR≤30 mg/g and eGFR≥90 mL/min/1.73 m2, n = 63) and DKD group (UACR>30 mg/g or eGFR<90 mL/min/1.73 m2, n = 119) excluding other causes of chronic kidney disease. We further developed diagnostic models to improve the ability to predict the risk of developing DKD by screening potential risk factors using univariate and multivariate logistic regression analysis. Calibration plots and curve analysis were used to validate the model and clinical usefulness. Next, we screened patients with relatively normal estimated glomerular filtration rate (eGFR) (≥90 mL/min/1.73 m2) to investigate whether tubular injury markers could accurately predict the risk of DKD in patients with normal renal function. We defined the rate of GFR decline as a prognostic indicator of renal function in patients and collected the information of the re-hospitalized DKD patients to determine whether the relevant indicators had an impact on the renal prognosis. Results: The patients with DKD had higher levels of tubular injury markers than patients with DM. URBP, α1-MG, eGFR were statistically different in both univariate and multivariate logistic regression analyses and displayed great predictive power after modeling with an area under curve of 0.987. The calibration curve showed medium agreement. Decision curve showed it would add more net benefits for clinical decision. After adjusting eGFR and serum creatinine (Scr), URBP was demonstrated to be associated with early renal function impairment. Conclusion: Tubular injury markers play an important role in early diabetic renal function impairment.

Diagnostic value of urine microalbuminuria in early renal damage of type 2 diabetic nephropathy

[Urinary Retinol Binding Protein and Β2-Microglobulin Were Associated with Urinary Albumin to Creatinine Ratio and Renal Function in Hospitalized Diabetic Patients].

Diagnostic Value of Urinary Retinal Binding Protein in Early Diabetic Nephropathy

Clinical application of urinary microalbumin/creatinine in random urine screening in patients with early diabetic nephropathy

Diagnostic value of α1-MG and URBP in early diabetic renal impairment

The value of urinary KIM-1,serum cystatin C in predicting the early diabetic nephropathy

Values of Combined Test of Cys-C HbA1c and U-mAlb /cr in Diagnosing Early Kidney Injury Secondary to Type 2 Diabetes Mellitus

Urinary orosomucoid and retinol binding protein levels as early diagnostic markers for diabetic nephropathy

Application of Urinary Albuminuria at Different Time in the Monitoring of Early Impairment in Kidney of Diabetes Mellitus

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Clinical significance of urine trace protein,urease and type IV collagen in early diagnosis of diabetic nephropathy

DIAGNOSTIC VALUE OF URINARY β2-MICROGLOBULIN IN PATIENTS WITH DIABETIC NEPHROPATHY

Urinary RBP As an Independent Predictor of Renal Outcome in Diabetic Nephropathy.

Correlation between urine vitamin D-binding protein and early-stage renal damage in Type 2 diabetes.

Diagnostic Value of the Combined Measurement of Serum Hcy, Serum Cys C, and Urinary Microalbumin in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy.

Diagnostic Value of Glomerular Filtration Rate, Microalbuminuria, Β2-Microglobulin and Cystatin C for Renal Function in Patients with Diabetic Nephropathy

The significance of urinary neutrophil gelatinase-associated lipocalin in the early diagnosis of diabetic nephropathy

Role of Beta Trace Protein and Cystatin C as a Potential Biomarker for Early Detection of Type 2 Diabetic Nephropathy

Value of Urinaryα1-Acid Glycoprotein in Early Diagnosis of Diabetic Nephropathy

Detected urinary microproteins for assessment of early diabetic renal damage

Diagnostic value of renal tubular function in subclinical diabetic nephropathy